Transforming growth factor-β1 hyperexpression in African-American hypertensives

A novel mediator of hypertension and/or target organ damage

Manikkam Suthanthiran, Baogui Li, Jong O. Song, Ruchuang Ding, Vijay K. Sharma, Joseph E. Schwartz, Phyllis August

Research output: Contribution to journalArticle

242 Citations (Scopus)

Abstract

Hypertension, a remediable risk factor for stroke, cardiovascular disease, and renal failure, affects 50 million individuals in the United States alone. African Americans (blacks) have a higher incidence and prevalence of hypertension and hypertension-associated target organ damage compared with Caucasian Americans (whites). Herein, we explored the hypotheses that transforming growth factor-β1 (TGF-β1) is hyperexpressed in hypertensives compared with normotensives and that TGF-β1 overexpression is more frequent in blacks compared with whites. These hypotheses were stimulated by our recent demonstration that TGF-β1 is hyperexpressed in blacks with end-stage renal disease compared with white end-stage renal disease patients and by the biological attributes of TGF-β1, which include induction of endothelin-1 expression, stimulation of renin release, and promotion of vascular and renal disease when TGF-β1 is produced in excess. TGF-β1 profiles were determined in black and white hypertensive subjects and normotensive controls and included circulating protein concentrations, mRNA steady-state levels, and codon 10 genotype. Our investigation demonstrated that TGF-β1 protein levels are highest in black hypertensives, and TGF-β1 protein as well as TGF-β1 mRNA levels are higher in hypertensives compared with normotensives. The proline allele at codon 10 (Pro10) was more frequent in blacks compared with whites, and its presence was associated with higher levels of TGF-β1 mRNA and protein. Our findings support the idea that TGF-β1 hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.

Original languageEnglish
Pages (from-to)3479-3484
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume97
Issue number7
Publication statusPublished - 28 Mar 2000
Externally publishedYes

Fingerprint

Transforming Growth Factors
African Americans
Hypertension
Codon
Messenger RNA
Chronic Kidney Failure
Proteins
Endothelin-1
Vascular Diseases
Renin
Proline
Renal Insufficiency
Cardiovascular Diseases
Stroke
Alleles
Genotype
Kidney

ASJC Scopus subject areas

  • General

Cite this

Transforming growth factor-β1 hyperexpression in African-American hypertensives : A novel mediator of hypertension and/or target organ damage. / Suthanthiran, Manikkam; Li, Baogui; Song, Jong O.; Ding, Ruchuang; Sharma, Vijay K.; Schwartz, Joseph E.; August, Phyllis.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 7, 28.03.2000, p. 3479-3484.

Research output: Contribution to journalArticle

@article{f431aa427279439c9aeef1580c7e5be0,
title = "Transforming growth factor-β1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage",
abstract = "Hypertension, a remediable risk factor for stroke, cardiovascular disease, and renal failure, affects 50 million individuals in the United States alone. African Americans (blacks) have a higher incidence and prevalence of hypertension and hypertension-associated target organ damage compared with Caucasian Americans (whites). Herein, we explored the hypotheses that transforming growth factor-β1 (TGF-β1) is hyperexpressed in hypertensives compared with normotensives and that TGF-β1 overexpression is more frequent in blacks compared with whites. These hypotheses were stimulated by our recent demonstration that TGF-β1 is hyperexpressed in blacks with end-stage renal disease compared with white end-stage renal disease patients and by the biological attributes of TGF-β1, which include induction of endothelin-1 expression, stimulation of renin release, and promotion of vascular and renal disease when TGF-β1 is produced in excess. TGF-β1 profiles were determined in black and white hypertensive subjects and normotensive controls and included circulating protein concentrations, mRNA steady-state levels, and codon 10 genotype. Our investigation demonstrated that TGF-β1 protein levels are highest in black hypertensives, and TGF-β1 protein as well as TGF-β1 mRNA levels are higher in hypertensives compared with normotensives. The proline allele at codon 10 (Pro10) was more frequent in blacks compared with whites, and its presence was associated with higher levels of TGF-β1 mRNA and protein. Our findings support the idea that TGF-β1 hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.",
author = "Manikkam Suthanthiran and Baogui Li and Song, {Jong O.} and Ruchuang Ding and Sharma, {Vijay K.} and Schwartz, {Joseph E.} and Phyllis August",
year = "2000",
month = "3",
day = "28",
language = "English",
volume = "97",
pages = "3479--3484",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

TY - JOUR

T1 - Transforming growth factor-β1 hyperexpression in African-American hypertensives

T2 - A novel mediator of hypertension and/or target organ damage

AU - Suthanthiran, Manikkam

AU - Li, Baogui

AU - Song, Jong O.

AU - Ding, Ruchuang

AU - Sharma, Vijay K.

AU - Schwartz, Joseph E.

AU - August, Phyllis

PY - 2000/3/28

Y1 - 2000/3/28

N2 - Hypertension, a remediable risk factor for stroke, cardiovascular disease, and renal failure, affects 50 million individuals in the United States alone. African Americans (blacks) have a higher incidence and prevalence of hypertension and hypertension-associated target organ damage compared with Caucasian Americans (whites). Herein, we explored the hypotheses that transforming growth factor-β1 (TGF-β1) is hyperexpressed in hypertensives compared with normotensives and that TGF-β1 overexpression is more frequent in blacks compared with whites. These hypotheses were stimulated by our recent demonstration that TGF-β1 is hyperexpressed in blacks with end-stage renal disease compared with white end-stage renal disease patients and by the biological attributes of TGF-β1, which include induction of endothelin-1 expression, stimulation of renin release, and promotion of vascular and renal disease when TGF-β1 is produced in excess. TGF-β1 profiles were determined in black and white hypertensive subjects and normotensive controls and included circulating protein concentrations, mRNA steady-state levels, and codon 10 genotype. Our investigation demonstrated that TGF-β1 protein levels are highest in black hypertensives, and TGF-β1 protein as well as TGF-β1 mRNA levels are higher in hypertensives compared with normotensives. The proline allele at codon 10 (Pro10) was more frequent in blacks compared with whites, and its presence was associated with higher levels of TGF-β1 mRNA and protein. Our findings support the idea that TGF-β1 hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.

AB - Hypertension, a remediable risk factor for stroke, cardiovascular disease, and renal failure, affects 50 million individuals in the United States alone. African Americans (blacks) have a higher incidence and prevalence of hypertension and hypertension-associated target organ damage compared with Caucasian Americans (whites). Herein, we explored the hypotheses that transforming growth factor-β1 (TGF-β1) is hyperexpressed in hypertensives compared with normotensives and that TGF-β1 overexpression is more frequent in blacks compared with whites. These hypotheses were stimulated by our recent demonstration that TGF-β1 is hyperexpressed in blacks with end-stage renal disease compared with white end-stage renal disease patients and by the biological attributes of TGF-β1, which include induction of endothelin-1 expression, stimulation of renin release, and promotion of vascular and renal disease when TGF-β1 is produced in excess. TGF-β1 profiles were determined in black and white hypertensive subjects and normotensive controls and included circulating protein concentrations, mRNA steady-state levels, and codon 10 genotype. Our investigation demonstrated that TGF-β1 protein levels are highest in black hypertensives, and TGF-β1 protein as well as TGF-β1 mRNA levels are higher in hypertensives compared with normotensives. The proline allele at codon 10 (Pro10) was more frequent in blacks compared with whites, and its presence was associated with higher levels of TGF-β1 mRNA and protein. Our findings support the idea that TGF-β1 hyperexpression is a risk factor for hypertension and hypertensive complications and provides a mechanism for the excess burden of hypertension in blacks.

UR - http://www.scopus.com/inward/record.url?scp=0034724167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034724167&partnerID=8YFLogxK

M3 - Article

VL - 97

SP - 3479

EP - 3484

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -